Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: persons (493), folks (1)

SoAR trainee reps role descriptor 16-11-2016

Description: Southampton Academy of Research Role Description Role Title: Southampton Academy of Research (SoAR) – early career researchers’ champion (cl
Url: /Media/Southampton-Clinical-Research/SoAR/SoAR-trainee-reps-role-descriptor-16-11-2016.docx

Annual ward staffing review January 2025

Description: [5.15] Report to the Trust Board of Directors, 7th January 2025 Title: Ward Staffing Nursing Establishment Review July 2024 – Octobe
Url: /Media/UHS-website-2019/Docs/About-the-Trust/performance/TB-6-monthly-staffing-review-report.pdf

Governors' Nomination Committee Terms of Reference 2025 Jan

Description: Governors’ Nomination Committee Terms of Reference Date Issued: Review Date: Document Type: 29 January 2025 January 2026 Committ
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Governors-Nomination-Committee-Terms-of-Reference-2025-Jan.pdf

Governors' Nomination Committee Terms of Reference Jan 2024

Description: Governors’ Nomination Committee Terms of Reference Date Issued: Review Date: Document Type: 31 January 2024 Ja
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Governors-Nomination-Committee-Terms-of-Reference-Jan-2024.pdf

DART study privacy notice

Description: Your role in improving the diagnosis of lung disease Information Sheet and Privacy Notice Oxford University is leading a proj
Url: /Media/UHS-website-2019/Docs/Services/Blood-heart-and-circulation/DART-study-privacy-notice.pdf

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description: Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pembrolizumab Indication - The patient has a histologically- or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

PV-CHP Cyclophosphamide-doxorubicin-polatuzumab vedotin -prednisolone

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-POLATUZUMAB VEDOTIN-PREDNISOLONE- RITUXIMAB Regimen • Lymphoma – Cyclophosphamide-doxorubicin-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/PV-CHP-Cyclophosphamide-doxorubicin-polatuzumab-vedotin-prednisolone.pdf

Governors' Nomination Committee Terms of Reference Dec 2022

Description: Governors’ Nomination Committee Terms of Reference Date Issued: Review Date: Document Type: 17 January 2023 January 2024 Committ
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Governors-Nomination-Committee-Terms-of-Reference-Dec-2022.pdf

RIPCORD Privacy Notice UHS v5

Description: This is a PRIVACY NOTICE for patients who took part in the RIPCORD 2 study Chief Investigator: Professor Nicholas Curzen
Url: /Media/Southampton-Clinical-Research/Downloads/RIPCORD-Privacy-Notice-UHS-v5.pdf

181 to 190 of 699

Previous … 17 18 19 20 21 … Next